Home » Topics » Regulatory » Patents

Patents
RSS

Lilly prepares compounds for controlling TxA2

Jan. 23, 1998

Inhibitors of prostaglandin biosynthesis prepared at Abbott

Jan. 23, 1998

Enantiomers of trans-benz[e]indoles selective for D3 receptors

Jan. 23, 1998

SmithKline Beecham presents new azetidinones for atherosclerosis

Jan. 23, 1998

Yamasa presents novel xanthine oxidase inhibitors

Jan. 22, 1998

Japan Energy describes inhibitors of SMC proliferation

Jan. 22, 1998

New 5-HT1B antagonists developed at SmithKline Beecham

Jan. 22, 1998

New cephems described by Fujisawa

Jan. 22, 1998

Pfizer presents new serotonergic agents

Jan. 22, 1998

Inhibitors of COX-1/COX-2 from Roche

Jan. 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...